Domain Therapeutics

View the org chart displaying its 13 main executives

Most searched biographies at Domain Therapeutics

• Sean Macdonald, Chief Executive Officer
• Roberto De Ponti, Director
• Laurence Rulleau, Director

Popular executive movements at Domain Therapeutics

• Sean Macdonald, who was Chief Business Officer, is promoted to Chief Executive Officer  (posted on April 18 2024).
• Anthony Johnson, President and Chief Executive Officer, has left the company  (posted on April 18 2024).
• Stephan Schann, who was Vice President of Research, is promoted to Chief Scientific Officer  (posted on February 28 2024).

Click here to view some more movements at Domain Therapeutics

Create your alert
to follow the executive moves at Domain Therapeutics.

Domain Therapeutics has 2,298 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology

• AltruBio has just announced a $225 Million fundraising (posted on May 24 2024).
• Genmab has acquired ProfoundBio (posted on May 23 2024).
• Centivo has announced the acquisition of Eden Health  (posted on May 23 2024).

Popular contacts in Biotechnology

• Ali Behbahani - Non-Executive Director at Adaptimmune Therapeutics
• Carl Gordon - Director at Adicet Bio
• Khalil Barrage - Interim Chairman of the Board at Sensorion

Learn more about the Biotechnology industry >

Press releases by Domain Therapeutics

Social media about Domain Therapeutics

• Domain Therapeutics on Wikipedia, Google News & Yahoo Finance
• Domain Therapeutics on LinkedIn, Twitter & YouTube

Contact by email its executives including Sean Macdonald

Call Domain Therapeutics at +44 203...

View the org chart

Register to receive your alert

Report an error